Proton Pump Inhibitor for Gastroesophageal Reflux Disease: Intelligent Prescription.
- Author:
Yun Ju JO
1
Author Information
1. Department of Internal Medicine, Eulji University School of Medicine, Seoul, Korea. jyj1138@eulji.ac.kr
- Publication Type:Review
- Keywords:
Gastroesophageal reflux;
Proton pump inhibitors;
Safety management
- MeSH:
Gastroesophageal Reflux;
Humans;
Phosphatidylethanolamines;
Prescriptions;
Proton Pump Inhibitors;
Proton Pumps;
Protons;
Safety Management
- From:Korean Journal of Medicine
2013;84(2):186-195
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Gastroesophageal reflux disease (GERD) has a chronicity and its symptoms wax and wane by proton pump inhibitor (PPI) therapy. Chronic consumption of PPI in the patients with GERD is common, and we can cope with a PPI failure or refractory GERD. Therefore, we review various alternative modalities for chronic PPI treatment and an approach for refractory GERD. PPI has a potential for side effects. Many studies have been published the side effects of long-term PPI using. Mostly clinical level of evidence is weak and the absolute risk is low, however we may discuss the patients who need long-term PPI therapy about the controversial side effects, and manage those appropriately.
